These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31876010)

  • 1. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Daliry A
    Microcirculation; 2020 Apr; 27(3):e12603. PubMed ID: 31876010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Ramos IP; da Silva IJ; Machado MP; Miranda RA; Pazos-Moura CC; Gonçalves-de-Albuquerque CF; Faria-Neto HCC; Tibiriça E; Daliry A
    PLoS One; 2017; 12(6):e0179654. PubMed ID: 28628674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress.
    Pereira ENGDS; Araujo BP; Rodrigues KL; Silvares RR; Martins CSM; Flores EEI; Fernandes-Santos C; Daliry A
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicinoid nonivamide improves nonalcoholic fatty liver disease in rats fed a high-fat diet.
    Wikan N; Tocharus J; Sivasinprasasn S; Kongkaew A; Chaichompoo W; Suksamrarn A; Tocharus C
    J Pharmacol Sci; 2020 Jul; 143(3):188-198. PubMed ID: 32414691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model.
    Allam MM; El Gazzar WB
    Arch Physiol Biochem; 2018 Feb; 124(1):10-17. PubMed ID: 28696785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
    Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
    Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol Exacerbates the Pathophysiology of Non-Alcoholic Steatohepatitis by Upregulating Hypoxia-Inducible Factor 1 and Modulating Microcirculatory Dysfunction.
    Pereira ENGDS; Araujo BP; Rodrigues KL; Silvares RR; Guimarães FV; Martins CSM; Flores EEI; Silva PMRE; Daliry A
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high-fat diet-/streptozotocin-induced diabetes.
    Silvares RR; Pereira EN; Flores EE; Estato V; Reis PA; Silva IJ; Machado MP; Neto HC; Tibiriça E; Daliry A
    Int J Exp Pathol; 2016 Jun; 97(3):266-77. PubMed ID: 27381700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
    El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
    Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
    Jeong MJ; Kim SR; Jung UJ
    Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigative effects of the bioactive flavonol fisetin on high-fat/high-sucrose induced nonalcoholic fatty liver disease in rats.
    Gaballah HH; El-Horany HE; Helal DS
    J Cell Biochem; 2019 Aug; 120(8):12762-12774. PubMed ID: 30861601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet.
    Haque MR; Ansari SH
    Hum Exp Toxicol; 2019 Jul; 38(7):823-832. PubMed ID: 30974975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoic Acid Prevents High-Fat Diet-Induced Hepatic Steatosis in Goto Kakizaki Rats by Reducing Oxidative Stress Through Nrf2 Activation.
    Sena CM; Cipriano MA; Botelho MF; Seiça RM
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
    Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
    Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.
    Tao W; Sun W; Liu L; Wang G; Xiao Z; Pei X; Wang M
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31744059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
    Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
    Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Rapeseed Oils Rich in Endogenous Micronutrients Protect High Fat Diet Fed Rats from Hepatic Lipid Accumulation and Oxidative Stress.
    Xu J; Liu X; Gao H; Chen C; Deng Q; Huang Q; Ma Z; Huang F
    Nutrients; 2015 Oct; 7(10):8491-502. PubMed ID: 26473919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.